Acute Myelomonocytic Leukemia

Search Trials
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Aug 12, 2004
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
tanespimycincytarabine
Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Apr 12, 2018
First Changed:
Jan 1, 1970
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
CytarabineDaunorubicin HydrochlorideDecitabineLaboratory Biomarker AnalysisPharmacological Study
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
Status:
Completed
Last Changed:
Sep 8, 2010
First Changed:
Sep 8, 2010
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
busulfancyclophosphamideallogeneic bone marrow transplantationmethylprednisolonemethotrexatecyclosporine
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Apr 6, 2013
First Changed:
Jan 1, 1970
Disease(s):
Adult Acute Basophilic Leukemia
Intervention(s):
cytarabinedaunorubicin hydrochlorideetoposidevalspodarfilgrastimbusulfanautologous hematopoietic stem cell transplantationperipheral blood stem cell transplantationaldesleukinclinical observationpharmacological study
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 2, 2017
First Changed:
Dec 4, 2006
Disease(s):
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Intervention(s):
AzacitidineEntinostatLaboratory Biomarker Analysis

Connect. Empower. Inspire.